AKRO.O
AKRO.O- Latest Trade
- trading lower--
- --
- --
- As of Mar 29 2023. Values delayed up to 15 minutes
- Today's Range
- -- - --
- 52 Week Range
- -- - --
Latest News
- BusinessMadrigal leads race for NASH treatments after trial success, shares surge
Madrigal Pharmaceuticals' experimental drug met the main goals in a eagerly anticipated late-stage study, propelling it to the forefront in the race for the first approved treatment for patients with advanced liver scarring.
- BusinessAkero's drug meets main goal in NASH trial, shares surge 120%
Akero Therapeutics Inc said on Tuesday its lead experimental drug met the main goal of a mid-stage study testing it as a treatment for a type of fatty liver disease that currently has no approved medicine on the market.
Markets Performance
Official Data PartnerCommodities
Future | Last | % Change |
---|---|---|
Gold | 1,972.40 | -- |
Copper | 792.65 | 0.58% |
Brent Crude Oil | 79.36 | 0.90% |
CBOT Soybeans | 1,466.75 | 0.07% |
Stocks
Index | Last | % Change |
---|---|---|
S&P 500 | 3,971.27 | -- |
Euro STOXX 50 | 4,214.08 | 1.10% |
FTSE 100 | 7,539.69 | 0.74% |
Nikkei 225 | 27,883.78 | 1.33% |
Source: Refinitiv, an LSEG business - data delayed by at least 15 minutes